Laura Bender

616 total citations
33 papers, 451 citations indexed

About

Laura Bender is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Laura Bender has authored 33 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Laura Bender's work include Lung Cancer Treatments and Mutations (11 papers), Glioma Diagnosis and Treatment (4 papers) and Meningioma and schwannoma management (4 papers). Laura Bender is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Glioma Diagnosis and Treatment (4 papers) and Meningioma and schwannoma management (4 papers). Laura Bender collaborates with scholars based in France, United States and Germany. Laura Bender's co-authors include Adam I. Marcus, Erik R. Kline, R. Donald Harvey, Yuan Liu, Thota Ganesh, Mourad Tighiouart, Jose Thaiparambil, Paula M. Vertino, Anapatricia García and Izzie Jacques Namer and has published in prestigious journals such as Cancer, Cancer Research and International Journal of Cancer.

In The Last Decade

Laura Bender

27 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Bender France 10 164 137 105 53 47 33 451
Melissa Rodríguez United States 10 382 2.3× 208 1.5× 143 1.4× 41 0.8× 22 0.5× 23 688
Alissar Monzer Lebanon 10 211 1.3× 37 0.3× 203 1.9× 70 1.3× 64 1.4× 20 460
Manman Deng China 15 342 2.1× 25 0.2× 141 1.3× 31 0.6× 20 0.4× 42 556
Chengsen Chai China 9 385 2.3× 49 0.4× 160 1.5× 68 1.3× 35 0.7× 10 561
Nathalie Bauer Germany 14 432 2.6× 37 0.3× 246 2.3× 39 0.7× 27 0.6× 20 690
Yusheng Shi China 14 356 2.2× 17 0.1× 60 0.6× 29 0.5× 90 1.9× 25 534
Shengchao Lin China 11 296 1.8× 56 0.4× 74 0.7× 69 1.3× 46 1.0× 12 497
Tianxiu Dong China 12 211 1.3× 15 0.1× 96 0.9× 36 0.7× 41 0.9× 19 373
Jianzhuang Ren China 12 180 1.1× 14 0.1× 82 0.8× 88 1.7× 31 0.7× 26 401

Countries citing papers authored by Laura Bender

Since Specialization
Citations

This map shows the geographic impact of Laura Bender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Bender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Bender more than expected).

Fields of papers citing papers by Laura Bender

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Bender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Bender. The network helps show where Laura Bender may publish in the future.

Co-authorship network of co-authors of Laura Bender

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Bender. A scholar is included among the top collaborators of Laura Bender based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Bender. Laura Bender is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bender, Laura, et al.. (2025). Evolving Therapeutic Landscape of ROS1-Positive Non-Small Cell Lung Cancer: An Updated Review. Current Oncology. 32(11). 626–626.
2.
Schött, Roland, et al.. (2024). Brain Metastases as Inaugural Sign of Non-Small Cell Lung Carcinoma: Case Series and Review of Literature. Cancers. 16(17). 3105–3105. 1 indexed citations
4.
Schött, Roland, et al.. (2024). Outcomes of non-small cell lung cancer patients with non-V600E BRAF mutations: a series of case reports and literature review. Frontiers in Oncology. 14. 1307882–1307882. 3 indexed citations
6.
Bender, Laura, Roland Schött, Anne‐Laure Charles, et al.. (2024). A single chemotherapy administration induces muscle atrophy, mitochondrial alterations and apoptosis in breast cancer patients. Journal of Cachexia Sarcopenia and Muscle. 15(1). 292–305. 10 indexed citations
8.
Demarchi, Martin, et al.. (2023). Anaplastic Lymphoma Kinase Inhibitor-Induced Neutropenia: A Systematic Review. Cancers. 15(20). 4940–4940. 1 indexed citations
9.
Bender, Laura, et al.. (2023). Capecitabine efficacy after cycline-dependent-kinase 4/6 inhibitor plus endocrine therapy in metastatic hormone receptor-positive breast cancer. Cancer Treatment and Research Communications. 36. 100738–100738. 1 indexed citations
11.
Bender, Laura, et al.. (2023). 68Ga-DOTATOC PET in Extracranial Hepatic and Bone Metastasis of Atypical Refractory Meningioma. Clinical Nuclear Medicine. 48(2). 176–178. 4 indexed citations
12.
Kurtz, Jean‐Emmanuel, Martin Demarchi, Xavier Pivot, et al.. (2022). A propensity score–weighted study comparing a two- versus four-weekly pegylated liposomal doxorubicin regimen in metastatic breast cancer. Breast Cancer Research and Treatment. 198(1). 23–29. 2 indexed citations
13.
Sebbag, E., Dimitri Psimaras, Seyyid Baloglu, et al.. (2021). Immune-Related Cerebellar Ataxia: A Rare Adverse Effect of Checkpoint Inhibitor Therapy. Journal of Neuroimmune Pharmacology. 17(3-4). 377–379. 6 indexed citations
14.
Bender, Laura, Benoît Lhermitte, Guido Ahle, et al.. (2021). High risk of recurrence for grade II meningioma: a 10-year multicenter analysis of prognosis factors. Chinese Clinical Oncology. 10(3). 26–26. 11 indexed citations
15.
Bender, Laura, et al.. (2020). Usefulness of 18F-FDOPA PET for the management of primary brain tumors: a systematic review of the literature. Cancer Imaging. 20(1). 70–70. 21 indexed citations
16.
Bender, Laura, Benoît Lhermitte, Seyyid Baloglu, et al.. (2019). Grade III meningioma with gastro-intestinal tract and brain metastases: case report and review of the literature. World Journal of Surgical Oncology. 17(1). 70–70. 6 indexed citations
17.
Bender, Laura, et al.. (2019). Ceritinib-related interstitial lung disease improving after treatment cessation without recurrence under either crizotinib or brigatinib: a case report. Annals of Translational Medicine. 7(5). 106–106. 11 indexed citations
18.
Bender, Laura, et al.. (2019). Efficiency of Nivolumab Considering Size of Tumor Thrombus in a Case of Metastatic Clear Cell Renal Cell Carcinoma with an Extensive Right Atrial Tumor Thrombus: A Case Report. 5(2).
19.
Yang, Lily, Hari Krishna Sajja, Zehong Cao, et al.. (2014). uPAR-targeted Optical Imaging Contrasts as Theranostic Agents for Tumor Margin Detection. Theranostics. 4(1). 106–118. 65 indexed citations
20.
Thaiparambil, Jose, Laura Bender, Thota Ganesh, et al.. (2011). Withaferin A inhibits breast cancer invasion and metastasis at sub‐cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation. International Journal of Cancer. 129(11). 2744–2755. 225 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026